Disease & Mechanisms

Synthesised from Atopic Dermatitis, Skin Barrier Dysfunction, Filaggrin, Natural Moisturising Factor, Transepidermal Water Loss, Skin pH, Skin Microbiome, Th2 Immune Response, Itch-Scratch Cycle, Lichenification, Staphylococcus aureus, Malassezia, Atopic March, Asthma, Allergic Rhinitis, Ichthyosis Vulgaris, Keratosis Pilaris, Eczema in Skin of Colour, Post-Inflammatory Hyperpigmentation, Eczema Prognosis, Eczema Trajectories and ALSPAC. Maps mainly onto infranodus clusters 1 (toddler, criteria, itch, march) and 2 (definition, dysfunction).

Overview

Atopic Dermatitis (AD, atopic eczema) is a chronic, itchy, relapsing inflammatory skin disease. It is the most common inflammatory skin disease worldwide, with about 230 million people affected. Onset is most common at 3–6 months: about 60% of cases start in the first year and about 90% by age 5. In the 1–4-year-old toddler window, eczema typically shifts from the cheeks and extensor surfaces of crawling infants to the flexures (elbow and knee creases, wrists, ankles). No laboratory test is needed to diagnose it.

The notes in this group describe one model of how the disease works. A defective outer skin layer (Skin Barrier Dysfunction) leaks water out, measured as raised Transepidermal Water Loss, and lets irritants, allergens and microbes in. The best-known genetic cause is loss-of-function mutation in Filaggrin, whose breakdown products form the water-binding Natural Moisturising Factor and help keep Skin pH acidic. Allergen entry primes a type 2 (Th2 Immune Response) inflammation, whose cytokines further suppress filaggrin and antimicrobial peptides. The less acidic, filaggrin-poor skin favours Staphylococcus aureus within a less diverse Skin Microbiome. Itch drives scratching, which damages the barrier again (Itch-Scratch Cycle). This explains why the same pieces keep appearing together: each one feeds the next.

The rest of the group covers what follows from this biology over time: comorbid Asthma and Allergic Rhinitis, the contested Atopic March, and birth-cohort data on Eczema Trajectories and Eczema Prognosis, much of it from the UK ALSPAC cohort. Related skin features, including Ichthyosis Vulgaris, Keratosis Pilaris, Lichenification and Post-Inflammatory Hyperpigmentation, and the different look of Eczema in Skin of Colour, round out the clinical picture.

Key Entities

Atopic Dermatitis

The American Academy of Dermatology defines AD as “a chronic, pruritic inflammatory skin disease that occurs most frequently in children”, often linked to raised IgE and a personal or family history of asthma or hay fever. Itch is the hallmark and drives most of the burden on children and families. Infants rub rather than scratch and the moist nappy area is usually spared. Toddlers develop flexural disease, perioral and chin dermatitis from dribble and food, and early Lichenification. NICE notes that in Asian, Black Caribbean and Black African children, extensor, discoid or follicular patterns may predominate. Infection is the main acute complication, with crusted, weeping flares often involving Staphylococcus aureus and the emergency of Eczema Herpeticum.

Skin Barrier Dysfunction

A healthy stratum corneum works like a brick wall: corneocytes packed with keratin and filaggrin-derived NMF, held together by a mortar of Ceramides, cholesterol and free fatty acids. In eczema, ceramide levels are lower, lipid chains shorter and the wall leaks both ways. Barrier problems persist even in skin that looks clear, and impairment tracks disease severity, which is the rationale for daily Emollient Therapy. Family history is the strongest everyday risk marker, but genes alone cannot explain the rapid rise in prevalence in industrialised countries. The Cork BASELINE cohort (Kelleher 2015, 1,903 infants) found that top-quarter Transepidermal Water Loss at day 2 and 2 months predicted AD at 12 months (AUC 0.81–0.84), direct evidence that the leaky barrier comes first. A 2024 home-measured study of 128 English infants did not reproduce this, a conflict the vault leaves unresolved.

Filaggrin

Filaggrin aggregates keratin filaments as skin cells flatten into corneocytes, and is later broken down (partly by caspase-14) into free amino acids, pyrrolidone carboxylic acid and urocanic acid. At least 49 truncating FLG mutations are known. Carriers have about 3.3 times the risk of eczema and tend to have earlier, longer-lasting disease, but most people with eczema have no FLG mutation. Reported carriage among Europeans with AD ranges from 10–50% to up to 60%, another recorded conflict. Filaggrin can also be lost without mutation, because IL-4 and IL-13 suppress its expression, so inflamed skin is filaggrin-poor. FLG loss is also the cause of Ichthyosis Vulgaris and is linked to Keratosis Pilaris. Kezic (2011) found NMF components lowest in FLG carriers but also reduced in AD patients without mutations.

Skin pH

The skin surface (acid mantle) sits at about pH 4–6. Newborn skin starts near-neutral and acidifies over the first year, fastest on the cheeks and other convex surfaces where infant eczema first appears. In AD, pH is highest in lesions and raised even in unaffected skin. A higher pH over-activates kallikrein 5 and 7, which loosen the stratum corneum and activate IL-1β. It also slows ceramide-making enzymes and helps S. aureus: the skin peptide dermcidin killed over 90% of S. aureus at pH 5.5 but only 60% at pH 6.5. Alkaline soap can raise skin pH by about 3 units for around 90 minutes, which is why filaggrin-deficient toddler skin copes poorly with soap.

Th2 Immune Response

Type 2 inflammation (IL-4, IL-5, IL-13, IL-31, IgE, eosinophils, mast cells) is the core immune signature of AD. When the barrier is breached, skin cells release TSLP, IL-33 and IL-25, which prime dendritic cells to push naive T cells towards the Th2 type. S. aureus superantigens and the house dust mite allergen Der p 1 also drive this pathway, and the same skin route of sensitisation underlies the Dual-Allergen Exposure Hypothesis for Food Allergy. IL-4 and IL-13 act through IL-4Rα and JAK–STAT signalling to lower filaggrin, loricrin, involucrin, ceramides and antimicrobial peptides, while IL-31 is the main itch cytokine. Chronic disease widens to Th1, Th17 and Th22 pathways. This is the biological basis of drugs such as Dupilumab and the JAK Inhibitors.

Staphylococcus aureus and the Skin Microbiome

A 2016 meta-analysis found S. aureus on 70% of eczema lesions, 39% of non-lesional skin and 62% of noses in people with AD, about 20 times the odds of controls on lesional skin. In children, colonisation rates of 57–100% are reported. Toxin-producing strains fuel itch and Th2 inflammation even when eczema does not look infected, but NICE stresses that colonisation is not infection. In the landmark Kong 2012 study of children with moderate–severe eczema, bacterial diversity fell during flares and S. aureus made up about 65% of bacteria in untreated flares, against about 15% with intermittent treatment. Diversity recovered before the eczema improved. Healthy skin is dominated by Coagulase-Negative Staphylococci, some of which kill S. aureus; such strains are scarcer on eczema skin. The yeast Malassezia acts in AD mainly as an allergen: its protein MGL_1304 is the main allergen in human sweat, which helps explain why heat and sweat worsen itch (adult and Asian data only).

Itch-Scratch Cycle

Itch is the defining symptom and the one most families call the worst. IL-31 and staphylococcal toxins drive it. Scratching damages the barrier, lets in more allergens and microbes and amplifies inflammation, which closes the loop. Eczema itch is not histamine-driven, so antihistamines do not stop it, and altered nerve fibres let light touch register as itch. A habit component builds up over time. Consequences for toddlers include Infected Eczema, Lichenification and Sleep Disturbance in Eczema: in ALSPAC (13,988 children), total sleep time was similar to peers but sleep quality was worse (aOR 1.48), even in mild eczema. The most effective anti-itch step is controlling inflammation with Emollient Therapy and Topical Corticosteroids.

Atopic March

The classic model runs from eczema in infancy to Food Allergy, then Asthma, then Allergic Rhinitis, explained by barrier-first sensitisation. Belgrave et al. (PLoS Med 2014; 9,801 children from MAAS and ALSPAC) found only 3.1% of all children, fewer than 7% of those with any symptoms, followed a march-like path. Eczema only (15.3%) was the largest affected group. Reviewers increasingly speak of “atopic multimorbidity”: conditions that co-occur and share risk factors without a fixed order. The vault records this as an unresolved conflict with the classic model.

Asthma and Allergic Rhinitis

The asthma link is real and dose-dependent: about 20% of children with mild AD have asthma, compared with over 60% with severe AD. Risk concentrates in the early-onset-persistent class, which carries FLG mutations and parental atopy. In the German Multicenter Allergy Study, early AD without early wheeze or sensitisation carried no extra wheeze risk at school age (aOR 1.11). Hay fever is the commonest later allergic condition: in the Swedish BAMSE cohort, 43.9% of children with persistent infantile eczema had rhinitis at 12, against 17.2% with asthma. No trial shows that better eczema treatment prevents either condition.

Eczema Trajectories and Eczema Prognosis

Paternoster et al. (JACI 2018) applied latent class analysis to ALSPAC (9,894 children to 16.5 years) and the Dutch PIAMA cohort, finding six reproducible patterns. About 58–63% of children were unaffected or had transient rash. Early-onset-early-resolving eczema (12.9–15.4%) peaked at 18–30 months and fell to about 10% by age 6–7. Early-onset-persistent eczema (4.9–7.3%) left about half still with rash at 16.5, and had the strongest links to FLG null mutations (OR 4.31). In the Multicenter Allergy Study, 43.2% of early AD was in complete remission by age 3, but 18.7% had symptoms every year; atopic sensitisation predicted a worse course (aOR 2.76). A 2016 meta-analysis found 80% of childhood AD no longer persisted 8 years after diagnosis. The overall message for parents is that many toddlers improve a lot or clear by school age, but a sizeable minority do not, and “clear” often means “quiet for now”.

Eczema in Skin of Colour

AD is at least as common, and by some reviews more common, in Black and Asian children, but most images and severity tools were built on light skin. On brown or black toddler skin, inflammation often looks violaceous, ashen-grey or darker brown rather than red. Follicular, papular and discoid patterns and extensor involvement are more frequent, which matters because “visible flexural dermatitis” is a core item in the UK Working Party Criteria. Darker-skinned children are also more prone to thick lichenification, Prurigo Nodularis and long-lasting Post-Inflammatory Hyperpigmentation. The National Eczema Society advises against continuing steroid on areas that are only discoloured, since PIH fades on its own over months and sun protection helps.

Associated skin features

Ichthyosis Vulgaris, the commonest inherited ichthyosis, is caused by FLG loss and shows as fine grey scale, most marked on the shins, from 2–6 months of age. About half to two thirds of people with it develop AD or other atopy, and it has been called a “forme fruste” of AD. Keratosis Pilaris gives harmless rough “chicken skin” bumps on the outer arms, thighs and, in young children, the cheeks, worse in winter. Lichenification is the thick, leathery skin of months of scratching, typically in the flexures from toddlerhood. It raises SCORAD and EASI scores, and severity is the strongest predictor of persistent eczema.

Connections Within This Community

Filaggrin [part-of] Skin Barrier Dysfunction Filaggrin [precedes] Natural Moisturising Factor Natural Moisturising Factor [supports] Skin pH Skin Barrier Dysfunction [causes] Transepidermal Water Loss Transepidermal Water Loss [precedes] Atopic Dermatitis Skin Barrier Dysfunction [causes] Atopic Dermatitis Th2 Immune Response [opposes] Filaggrin Skin pH [supports] Staphylococcus aureus Staphylococcus aureus [part-of] Skin Microbiome Staphylococcus aureus [worsens] Atopic Dermatitis Itch-Scratch Cycle [causes] Lichenification Filaggrin [causes] Ichthyosis Vulgaris Atopic Dermatitis [relates] Asthma Atopic March [contradicts] Eczema Trajectories ALSPAC [defines] Eczema Trajectories Eczema in Skin of Colour [relates] Post-Inflammatory Hyperpigmentation

Bridges to Other Communities

Open Questions